PYC.L Gross Margin

The Gross Margin of Physiomics PLC (PYC.L) is -92.46%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

PYC.L Gross Margin - Historical Value

Date	Value
2024-06-30	-92.46%

PYC.L Gross Margin - Peers Comparison

Ticker	Name	Value
BANB.SW	Bachem Holding AG	30.16%
AROC.ST	AroCell AB (publ)	20.43%
EVT.DE	Evotec SE	14.41%
IXI.L	IXICO PLC	47.02%
SLV.WA	Selvita SA	78.54%
DVRG.L	Deepverge PLC	57.12%
ERGO.L	Ergomed PLC	40.72%
OBD.L	Oxford Biodynamics PLC	45.44%
RVU.WA	Ryvu Therapeutics SA	69.58%
PANG.MC	Pangaea Oncology SA	66.03%
RP.V	Replicel Life Sciences Inc	100.00%
C4XD.L	C4X Discovery Holdings PLC	97.78%
FAB.L	Fusion Antibodies PLC	21.88%
PRM.L	Proteome Sciences PLC	13.71%
QMDT	Quick-Med Technologies Inc	97.31%
ALIF B.ST	AddLife AB	38.25%
ERF.PA	Eurofins Scientific SE	22.33%
GLG.WA	GLG Pharma SA	-115.29%
IGN.WA	Hyenergy SA	39.27%
LAXAF	Laxai Pharma Ltd	34.97%
GENO.ST	Genovis AB	88.20%
IOT.V	Innovotech Inc	50.59%
PBIO	Pressure Biosciences Inc	40.43%
PRTC.L	PureTech Health PLC	100.00%
ALECR.PA	Eurofins-Cerep SA	86.74%
EEP.MC	Euroespes SA	50.86%